Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Oct 08, 2020 10:15 AM - Oct 09, 2020 2:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

Master Protocol Workshop

Session 3: Lessons Learned from Ongoing Master Protocol Platform Trial

Session Chair(s)

Michelle  Detry, PhD

Michelle Detry, PhD

Director, Adaptive Trial Execution & Senior Statistical Scientist

Berry Consultants LLC, United States

AnnCatherine M. Downing, PharmD

AnnCatherine M. Downing, PharmD

Chief Operating Officer - Lilly Research Laboratories

Eli Lilly and Company, United States

This session will present lessons learned from a newly initiated Master Protocol Trial regarding strategy and design choice, operational challenges and disclosure considerations, and the role of patients and advocacy groups in the platform trial development. This session will feature the experiences from the newly initiated HEALEY ALS (Amyotrophic Lateral Sclerosis) Platform Trial.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Discuss the rationale for choosing a Master Protocol Platform Trial design and key design features
  • Identify the unique operational challenges and disclosure considerations required for implementing a Master Protocol Platform Trial
  • Summarize the role of patient and advocacy groups and perspective towards Master Protocol Platform Trials


Sabrina  Paganoni, MD, PhD


Sabrina Paganoni, MD, PhD

Harvard Medical School, Healey Center for ALS at Mass General, United States

Assistant Professor

Marianne K Chase


Marianne K Chase

Neurological Clinical Research Institute, Massachusetts General Hospital, United States

Senior Director of Clinical Trial Operations

Philip John Green


Philip John Green

CTTI, United States

Steering Committee Patient Representative

Sundeep Surendra Sethi, MD, MBA


Sundeep Surendra Sethi, MD, MBA

AbbVie, Inc., United States

Vice President, Safety Operations

Stephen  Finger, PhD


Stephen Finger, PhD

HEALEY ALS Platform Trial Patient Advisory Committee, United States

ALS Patient Advocate

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.